# MEsenchymal StEm Cells for Multiple Sclerosis

> **NCT01854957** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Antonio Uccelli** · enrollment: 20 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** Autologous Mesenchymal Stem Cells

## Key facts

- **NCT ID:** NCT01854957
- **Lead sponsor:** Antonio Uccelli
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-05-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854957, "MEsenchymal StEm Cells for Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01854957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*